1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Mani, Inc.

Mani, Inc.

TTSE:7730
1,538.00
JPY
+9.00
(+0.59%)
165.09BMarket Cap
Jan 13Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
92.83
115.18
139.27
167.24
174.42
204.24
186.2
154.43
174.65
207.42
248.71
289.48
304.26
- -
Basic EPS, GAAP
21.66
26.24
29.53
30.36
33.68
38.31
61.99
33.82
43.6
53.75
60.46
63.82
47.14
- -
Free Cash Flow per Basic Share
8.86
24.08
16.05
9.43
25.01
43.75
40.42
2.53
25.63
46.89
43.73
1.31
3.52
- -
Dividend per Share
6.93
7.12
8.66
9.57
10.69
11.65
18.01
20.98
22
24
31.98
37.02
38.99
- -
Book Value per Share
210.04
235.29
275.2
272.09
309.65
340.83
358.92
371.5
398.28
461.39
505.86
531.17
543.75
575.23
Tangible Book Value per Share
209.24
234.6
257.1
255.78
293.93
331.53
349.55
362.15
389.18
450.88
493.24
517.59
530.13
562.24
Basic Weighted Avg Shares
101
99
99
99
98
98
98
98
98
98
98
98
98
99
Sales/Revenue/Turnover
9,342
11,440
13,833
16,555
17,168
20,103
18,327
15,200
17,190
20,416
24,488
28,513
29,968
- -
Operating Margin (%)
32.3
34.09
30.21
25.65
24.82
25.27
32
28.56
31.11
30.19
29.58
29.43
27.34
- -
Depreciation Expense
575
709
889
1,210
1,304
1,478
1,365
1,411
1,541
1,745
1,917
2,270
2,471
- -
Net Income, GAAP
2,180
2,607
2,933
3,006
3,315
3,771
6,102
3,329
4,291
5,290
5,953
6,286
4,643
- -
Effective Tax Rate (%)
35.62
33.86
32.81
25.85
28.65
27.33
27.35
31.09
28.5
28.7
25.74
25.37
34.47
- -
Profit Margin (%)
23.34
22.78
21.2
18.16
19.31
18.76
33.29
21.9
24.96
25.91
24.31
22.05
15.49
- -
Working Capital
11,371
12,350
12,511
12,146
13,263
17,492
21,803
24,258
25,072
28,719
30,776
28,030
26,484
29,389
LT Debt
- -
- -
- -
- -
- -
- -
- -
17
59
30
17
44
27
26
Total Equity
20,863
23,371
27,335
26,781
30,478
33,547
35,327
36,565
39,201
45,413
49,826
52,330
53,561
56,662
Return on Invested Capital (%)
9.42
11.34
10.75
11.39
10.37
11.24
11.97
8.1
9.9
10.1
11
11.99
9.93
- -
Return on Capital (%)
10.9
11.79
11.57
11.11
11.58
11.78
17.72
9.26
11.3
12.47
12.48
12.3
8.76
- -
Return on Common Equity (%)
10.9
11.79
11.57
11.11
11.58
11.78
17.72
9.26
11.33
12.5
12.5
12.31
8.77
- -

Capital Structure

JPY

•

in mil. unless spec.
Aug'25
Nov'26
Feb'26
ST Debt
49
- -
38
LT Borrowings
- -
- -
- -
LT Finance Leases
27
- -
26
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
99
99
99
Market Capitalization
121,848
144,306
165,090

Working Capital

JPY

•

in mil. unless spec.
Aug'25
Nov'26
Feb'26
Total Current Assets
29,978
- -
33,273
Cash, Cash Equivalents & STI
18,734
- -
22,845
Accounts Receivable, Net
2,973
- -
3,070
Inventories
6,337
- -
6,583
Total Current Liabilities
3,494
- -
3,884
Payables & Accruals
- -
- -
- -
ST Debt
49
- -
38
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.08%
8.03%
2.35%
Free Cash Flow
115.73%
212.29%
168.99%
Net Income, GAAP
8.71%
8.83%
-26.14%
Sales/Revenue/Turnover
8.79%
14.67%
5.1%
Total Cash Common Dividend
16.96%
13.67%
5.32%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,114
6,794
7,702
6,903
28,513
2025
- -
- -
- -
- -
29,968
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
15.97
16.43
19.2
12.22
63.82
2025
- -
- -
- -
- -
47.14
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
37.02
2025
- -
- -
- -
- -
38.99
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Masaya Watanabe
Full Time Employees
4,140
Sector
Health technology
Industry
Medical specialties
Address
8-3 Kiyohara Industrial Park Utsunomiya TO Japan 321-3231
IPO Date
Jun 29, 2001
Website
mani.co.jp
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Mani, Inc. Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments, operating through three primary segments: surgical products, eyeless needle products, and dental products. The company offers surgical instruments including maniplers, vessel knives, ENT knives, stainless wire needles, saws, septum stitch tools, and stent graft metal skeletons for incision, cutting, and suturing in general surgical operations; ophthalmic instruments such as ophthalmic sutures, knives, and trocar kits for cataract operations, vitrectomy, corneal surgery, and glaucoma treatments; suture needles encompassing eyeless, eyed, taper point, and cutting varieties for surgical and ophthalmic applications; and dental instruments comprising endodontic instruments, endodontic rotary instruments, root canal obturation systems, diamond and carbide burs, finishing and polishing instruments, sutures, surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. conducts its operations in Japan, Asia, Europe, North America, and other international markets, importing and selling select medical devices while targeting healthcare providers, hospitals, and dental professionals. Founded in 1956 and headquartered in Utsunomiya, Japan, the company maintains consolidated subsidiaries including Mani Medical America to support global distribution. In April 2025, Mani, Inc. entered a strategic partnership with Microsurgical Technology (MST), designating MST as the exclusive distributor of its ophthalmic surgical blade portfolio in the United States through Mani Medical America, enhancing market access for blades used in cataract, corneal, and glaucoma procedures while expanding into custom kit packing.